SecBot SecBot
DEFA14A ·Filed Apr 27, 2026

VOR

Vor Biopharma Inc.
NEUTRAL
Impact 2/10
Horizonmonths Processed6mo ago SEC0001193125-26-181892
Proxy solicitation materials
Actionable Insight • Neutral

No actionable content available from this filing. Monitor future filings for proxy details or a readable definitive proxy statement.

DirectionNeutral
Confidencelow
Horizonmonths

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$14.38
T+0 close · Apr 27, 2026 · via day close
Latest settled
+31.99%
T+60 · $18.98
Vs SPY
+28.00%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 28 $14.38entry
  2. T+1 · 7mo ago −1.88%α −1.87% · $14.11
  3. T+5 · 7mo ago +2.29%α +0.60% · $14.71
  4. T+20 · 6mo ago −1.95%α −7.42% · $14.10
  5. T+60 · 4mo ago +31.99%α +28.00% · $18.98
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Analysis based on filing metadata only, document content was unavailable. Vor Biopharma filed a DEFA14A (additional definitive proxy soliciting materials) on April 27, 2026. Without readable content, the specific proposals or solicitation details cannot be assessed.

Key Facts

  • Form DEFA14A filed by Vor Biopharma Inc. (VOR) on April 27, 2026
  • Filing relates to proxy solicitation materials under Rule 14a-12
  • Document content is not readable (binary/encoded)
  • Market cap ~$675M; recent insider selling of $41.6M over 30 days

Financial Impact

Not determinable from unavailable content

Risk Factors

  • Lack of transparency due to unreadable filing
  • Potential material information missed without readable document

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
85% bullish (13 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001193125-26-181892
Document: 0001193125-26-181892-index-headers.html0001193125-26-181892
Document: 0001193125-26-181892-index.html0001193125-26-181892
Document: 0001193125-26-181892.txt0001193125-26-181892

Track record

17 reports on VOR

Performance horizon

3 of 4 bullish or bearish reports moved the stock their way by T+1. Best: +70.35% at T+60 after the Jun 8, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $18.97 Now $18.97 −0.00% settles Nov 18
  2. Nov 12, 20264d ago 8-K Neutral 5/10 Entry $19.32 to $19.42 Now $18.97 −1.81% ▲ +0.52% +0.88% vs SPY
  3. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $18.66 to $19.88 Now $18.97 +1.66% ▲ +6.54% +6.23% vs SPY
  4. Oct 30, 202617d ago 424B5 Bearish 4/10 Entry $19.68 to $19.25 Now $18.97 +3.61% ▲ +2.19% +1.71% vs SPY
  5. Oct 30, 202617d ago Press Release Neutral 4/10 Entry $19.68 to $19.25 Now $18.97 −3.61% ▼ −2.19% −1.71% vs SPY
  6. Oct 22, 202625d ago Press Release Bullish 7/10 Entry $18.26 to $18.33 Now $18.97 +3.89% ▲ +0.38% −0.33% vs SPY
  7. Oct 5, 20266w ago Press Release Neutral 2/10 Entry $18.31 to $18.78 Now $18.97 +3.60% ▲ +2.57% +2.81% vs SPY
  8. Sep 29, 20266w ago Press Release Bullish 6/10 Entry $18.33 to $19.08 Now $18.97 +3.49% ▲ +4.09% +4.30% vs SPY
  9. Aug 11, 202613w ago Press Release Neutral 3/10 Entry $23.37 to $22.34 Now $18.97 −18.83% ▼ −4.41% −4.66% vs SPY
  10. Jul 9, 202618w ago 3 Neutral 2/10 Entry $19.14 to $18.03 Now $18.97 −0.89% ▼ −5.80% −5.03% vs SPY
Showing 10 of 17

US Market Status

Market Closed · Opens in 6h 34m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 27, 2026